Search

everythinglearnresearchcommunity

for

Search:↓

5 alpha-reductase inhibitors can slightly improve symptoms of enlarged prostate but have a high risk of sexual side effects.

The new delivery system improves treatment for hair loss by enhancing drug absorption and effectiveness.

Apremilast was not effective in treating moderate-to-severe alopecia areata.

Ritlecitinib effectively promotes hair regrowth in alopecia areata patients, even with extensive hair loss.

Mixing platelet-rich plasma with triamcinolone acetonide can potentially improve hair regrowth in alopecia areata patients.

Combining Ficlatuzumab and Gefitinib can cause severe hair loss.

Infliximab was effective in treating a scalp condition that did not respond to other treatments.

Some hair loss drugs can cause a unique type of hair loss that resembles both psoriasis and alopecia.

TAK-279 effectively reduces psoriasis symptoms and is safe.

RUM-loaded SLN shows promise for treating acne and hair loss topically.

Tamsulosin and solifenacin together effectively reduce symptoms in BPH patients.

Cyproterone acetate with estradiol may subjectively improve excessive hair growth in women, but it's not clinically better than other treatments.

Clofazimine may be effective for treating ashy dermatosis.

Anifrolumab helped some lupus patients reduce steroid use, but safety concerns remain.

LPA3 signaling in the uterus is crucial for placental formation and fetal development.

Tribulus terrestris may protect the liver from drug damage.

Baricitinib is effective and cost-efficient for treating severe alopecia areata in adults.

Rapamycin may help treat Leigh syndrome by targeting protein kinase C.

Tofacitinib may help treat both alopecia areata and inflammatory bowel disease.

Intralesional triamcinolone acetonide is more effective than platelet-rich plasma for treating scalp alopecia areata.

Dupilumab may cause significant hair loss, which can reverse after stopping the drug.

A woman with severe angioedema improved significantly after treatment with rituximab.

JAK inhibitors are effective and safe for treating severe alopecia areata.

Dual-targeted therapy is effective and safe for difficult-to-treat inflammatory bowel disease.

The use of Diane-35 and its generics significantly decreased in the Netherlands.

Combining gemcitabine with paclitaxel is more effective than with pemetrexed for advanced lung cancer.

New treatments for lupus show promise, but more research is needed, especially for children.

Hormone-replacement therapy improved a woman's skin condition known as lymphomatoid papulosis.

Continued ritlecitinib treatment can lead to hair regrowth in some patients with alopecia areata who initially don't respond.